Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
- Liao, Linda M.
- Vaughan, Thomas L.
- Corley, Douglas A.
- Cook, Michael B.
- Casson, Alan G.
- Kamangar, Farin
- Abnet, Christian C.
- Risch, Harvey A.
- Giffen, Carol
- Freedman, Neal D.
- Chow, Wongho
- Sadeghi, Shahram
- Pandeya, Nirmala
- Whiteman, David C.
- Murray, Liam J.
- Bernstein, Leslie
- Gammon, Marilie D.
- Wu, Anna H.
Publication date
January 2012
DOIAbstract
Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAID) has been reported to reduce risks for esophageal adenocarcinoma (EAC) and esophagogastric junctional adenocarcinoma (EGJA). However, individual studies have been too small to accurately assess the effects of medication type, frequency, or duration of use. We performed a pooled analysis to investigate these associations
Add to ORKG